Skip to main content

Table 4 Follow-up changes in MetS after chemotherapy among early stage breast cancer patients

From: Metabolic syndrome and breast cancer survivors: a follow-up analysis after completion of chemotherapy

Variable

Pre-treatmenta

Post-treatmenta

Follow-upa

% Change+

P+

Waist circumference, cm

86.7 (12.9)

90.7 (11.2)

93.2 (12.2)

2.7

P < 0.01

Blood pressure, mmHg

 Systolic

122 (25)

128 (27)

133 (25)

3.8

P < 0.01

 Diastolic

83 (13)

90 (18)

94 (20)

4.3

 

Fasting blood glucose, mg/dL

97.2 (19.8)

117.0 (37.0)

125.2 (41.0)

6.6

P < 0.01

Triglycerides, mg/dL

108.7 (47.6)

128.7 (58.9)

144.6 (16.1)

11.0

P < 0.01

HDL-C, mg/dL

57.9 (12.0)

50.6 (14.9)

42.9 (16.8)

− 17.9

P < 0.01

# MetS components

1.0 (0.5)

4.0 (1.0)

4.0 (1.0)

0.0

P = 0.98

  1. HDL-C high-density lipoprotein-cholesterol, MetS metabolic syndrome
  2. aMean (± SD)
  3. +From post-treatment to follow-up